查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
ADHD（注意力缺陷多動障礙）全球市場規模、份額、行業趨勢分析報告：2022-2028 年按藥物類型、人口統計、分銷渠道、地區分列的展望和預測
市場調查報告書
商品編碼
1172732

ADHD（注意力缺陷多動障礙）全球市場規模、份額、行業趨勢分析報告：2022-2028 年按藥物類型、人口統計、分銷渠道、地區分列的展望和預測

Global Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 294 Pages | 訂單完成後即時交付

價格

在預測期內，ADHD（注意力缺陷多動障礙）的全球市場規模預計將以 4.0% 的複合年增長率增長，到 2028 年將達到 169 億美元。

因此，兒童多動症的患病率受到密切關注，了解這一點對於未來的服務規劃、培訓、資源分配和研究目標至關重要。 幾項評論顯示，全世界青少年和兒童的患病率範圍很廣，從低至近 1% 到高達 20% 或更高。

ADHD 使用最廣泛的標準是美國精神病學協會出版的《精神障礙診斷和統計手冊》(DSM-IV) 中的標準。 該標準根據主要症狀模式將 ADHD 分為三種亞型：多動-衝動型、注意力不集中和復雜型。 此外，DSM-IV ADHD 診斷通常與焦慮和抑鬱等疾病有關。

COVID-19 影響分析

多動症患者在大流行期間受到重創，因為他們更容易因封鎖措施和保持社交距離而感到不適。 這些干預措施導致患有多動症的人表現出更多的行為問題。 症狀的普遍性不僅增加了患者的不適感，也增加了他們的家人的不適感。 隨著消費者恐慌並囤積必需品，急需的藥物出現供應短缺，迫使市場參與者利用更新的藥物。 這也適用於 ADHD 治療。

市場增長因素

它可以提高殘疾人的自尊和自我意識

如果不及時治療，多動症會對患者的健康構成重大威脅。 結果，焦慮、抑鬱和躁鬱症的發病率增加。 因此，直接與患者打交道的人也感到苦惱。 此外，失望和沮喪會增加患上反社會人格障礙的機率。

提高對行為療法有用性的認識

治療 ADHD 有兩種重要方法，將兩者結合使用往往效果最佳。 因此，藥物和行為療法的結合可以更好地控制 ADHD 的治療。 行為療法最近受到多動症兒童家長的廣泛關注。 處於這些情況下的父母和孩子正在參加專家課程，以幫助管理和減輕 ADHD 的後果。

市場製約因素

藥物治療的顯著副作用

已經進行了許多研究來治療 ADHD 症狀，但沒有發現非常有效。 此外，以前研究中獲得的數據不足以批准開發配方。 因此，ADHD 藥物目前只能治療某些患者群體或某些症狀。 此外，這些藥物的作用方式不同，因此有副作用。 從我們收集的數據中我們也知道，副作用比預期的要突出。

藥物類型展望

根據藥物類型，ADHD（注意力缺陷多動障礙）市場分為興奮劑藥物和非興奮劑藥物。 興奮劑部分在 2021 年提高了 ADHD（注意力缺陷多動障礙）市場的最高收入份額。 這些是 ADHD（注意力缺陷多動障礙）最常用的處方藥。 這些藥物可以幫助您保持精神集中並忽略干擾。 大多數患有多動症的人都報告說使用興奮劑藥物很成功。 這些通常用於治療重度和中度多動症。 它們可能對在學校、家庭或工作中掙扎的兒童、青少年和成年人有用。

興奮劑的前景

興奮劑部分進一步分為安非他明、□醋甲酯、lisdexamphetamine 和 dexmethylphenidate。 到 2021 年，苯丙胺細分市場在 ADHD（注意力缺陷多動障礙）市場的收入份額最大。 苯丙胺或右旋苯丙胺是一種強大的中樞神經系統 (CNS) 興奮劑。 這些藥物間接充當擬交感神經胺，也用於治療多動症、發作性睡病和多動症。 此類藥物可以幫助您專注於任何活動、提高警覺性並控制衝動行為症狀。

無刺激性的前景

非興奮劑部分進一步細分為托莫西汀、胍法辛、可樂定等。 2021 年，托莫西汀細分市場在 ADHD（注意力缺陷多動障礙）市場中佔據了最大的收入份額。 與其他 ADHD 藥物相比，托莫西汀的作用不同。 Atomoxetine 是一種選擇性去甲腎上腺素再攝取抑製劑 (SNRI)，因此可增加大腦中去甲腎上腺素的水平，而去甲腎上腺素可在腦細胞之間傳遞信息。 通過增加這種神經遞質，患有多動症的人可以改善注意力和衝動控制。

人口統計展望

ADHD（注意力缺陷多動障礙）市場根據人口統計數據分為兒童（2-17 歲）和成人。 在 2021 年的 ADHD（注意力缺陷多動障礙）市場中，兒科領域的收入份額相當可觀。 患有多動症的兒童發現很難控制衝動行為，從言語到動作再到注意力集中。 結果，這些孩子有時被稱為麻煩製造者，並因懶惰和缺乏紀律而受到責罵。

分銷渠道前景

ADHD（注意力缺陷多動障礙）市場按分銷渠道分為零售藥店和醫院藥店。 2021 年，零售藥房部門在 ADHD（注意力缺陷多動障礙）市場中的收入份額最大。 大多數 ADHD 患者在門診接受治療，這是該領域增長的主要驅動力。 注意力也集中在患者護理計劃上，為患者提供個人電子健康記錄 (EHR)，以記錄他們的病史並接受初級護理。

區域展望

注意缺陷/多動障礙 (ADHD) 市場按北美、歐洲、亞太地區和 LAMEA 地區進行分析。 2021 年，北美部分在 ADHD（注意力缺陷多動障礙）市場中佔據了最大的收入份額。 各種 ADHD 療法的廣泛引入和快速接受是影響該細分市場增長的主要因素。 更好的患者負擔能力、有利的報銷政策以及公眾對當前治療方式的認識不斷提高，預計會進一步增長。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • ADHD（注意缺陷多動障礙）藥物類型的全球市場
    • 全球注意力缺陷多動障礙 (ADHD) 市場（按人口統計）
    • 全球 ADHD 市場：按分銷渠道
    • ADHD（注意力缺陷多動障礙）全球市場，按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章 ADHD（注意力缺陷/多動障礙）市場策略部署

第 4 章全球 ADHD 市場：按藥物類型分類

  • 全球興奮劑市場：按地區
  • 按興奮劑類型：全球 ADHD（注意力缺陷多動障礙）市場
    • 全球苯丙胺市場：按地區
    • 全球□醋甲酯市場：按地區分類
    • 全球 Lisdexamfetamine 市場：按地區
    • 全球 Dexmethylphenidate 市場：按地區
  • 非興奮劑的全球市場：按地區
  • ADHD（注意力缺陷/多動障礙）的全球市場：按非興奮劑類型
    • 全球托莫西汀市場：按地區
    • 全球胍法辛市場：按地區
    • 可樂定全球市場：按地區
    • 按地區劃分的其他全球市場

第 5 章 ADHD 全球市場：按人口統計

  • 全球成人市場：按地區
  • 全球兒童市場：按地區

第 6 章 ADHD 全球市場：按分銷渠道

  • 全球零售藥店市場，按地區
  • 全球住院藥房市場：按地區

第 7 章 ADHD（注意力缺陷/多動障礙）全球市場：按地區劃分

  • 北美
    • 北美 ADHD 市場：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲 ADHD 市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區 ADHD 市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 的 ADHD 市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 拉美其他地區

第八章公司簡介

  • Eli Lilly And Company
  • Pfizer, Inc.（Global Blood Therapeutics, Inc.）
  • Lupin Limited
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mallinckrodt PLC
  • Purdue Pharma L.P
  • Aytu BioPharma, Inc.
  • Supernus Pharmaceuticals, Inc.

The Global Attention Deficit Hyperactivity Disorder Market size is expected to reach $16.9 billion by 2028, rising at a market growth of 4.0% CAGR during the forecast period.

Attention deficit hyperactivity disorder, or ADHD, is a common psychiatric disorder that starts during childhood. This widespread neurodevelopmental disorder is typically identified for the first time in childhood and frequently persists into maturity. Children with ADHD might struggle to focus, manage impulsive behaviors (doing without considering the consequences), or be highly active. This disorder is also called as hyperkinetic disorder (HKD).

It is normal for kids to struggle with their manners and attention spans occasionally. The symptoms persist, can be unpleasant, and make it difficult to interact with friends, family, or co-workers. As a significant public health issue, ADHD has been linked to a wide range of adverse health outcomes for those affected and considerable cost burdens for their families and societies at large.

As a result, children's ADHD prevalence has come under scrutiny, and understanding it is essential for future service planning, training, resource allocation, and research goals. According to several reviews, prevalence rates among adolescents and children worldwide ranged widely, from as low as almost 1% to as significant as over 20%.

The most widely used criteria for ADHD are those found in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) published by the American Psychiatric Association. These criteria divide ADHD into three subtypes based on the predominating symptom pattern: hyperactive-impulsive type, inattentive type, and combined type. The DSM-IV diagnosis of ADHD also allows for the occurrence of frequent co-occurring disorders like anxiety or depression.

COVID - 19 Impact Analysis

Given their susceptibility to the discomfort caused by the lockdown measures and social distancing measures, people with ADHD had a terrible experience during the pandemic. These interventions caused people with ADHD to display more behavioral issues. The prevalence of symptoms increased the discomfort for the patient as well as their families. Additionally, market players had to utilize novel medicines because necessary drugs ran out of supply due to consumers' action of panic buying necessities as a precaution. This also applied to the treatments for ADHD.

Market Growth Factors

Enabling the disorder sufferer to build self-esteem and self-awareness

When ADHD is left untreated, it severely threatens the patient's well-being. As a result, the development of anxiety, depression, and bipolar disorder increases. Consequently, this also makes the situation hard for those directly involved with the sufferers. In addition, the mounting disappointments and frustrations can further accelerate the chances of forming antisocial personality disorder.

Increasing recognition of behavioral therapy benefits

Although there are two significant ways to treat ADHD, combining the two frequently yields the best outcomes. Therefore, medication combined with behavioral therapy provides better control of the treatment of ADHD. Recently, behavioral therapies have gained significant attention from parents who have children with ADHD. Parents and kids in this situation attend specialist lessons to manage and reduce the consequences of ADHD.

Market Restraining Factors

Prominent side-effects of medications

While the number of studies being conducted on the curative measurements of ADHD symptoms, nothing highly effective has been found. Furthermore, the available data from previous studies lack sufficient approval for the formulas to be developed. The available medicines for ADHD, hence, are only able to treat either a specific patient group or only some symptoms. In addition, these medications do not work the same and, therefore, deliver side effects. From the collected data, it has also been found that the prominence of side effects is also highly unexpected.

Drug Type Outlook

Based on drug type, the attention deficit hyperactivity disorder market is categorized into stimulants and non-stimulants. The stimulants segment procured the highest revenue share in the attention deficit hyperactivity disorder market in 2021. These are the most frequently prescribed drugs for attention deficit hyperactivity disorder. These drugs may aid in maintaining mental focus and ignoring distractions. Most patients with ADHD have reported success with stimulant medications. These are usually prescribed for the treatment of severe and moderate ADHD. They might be helpful for kids, adolescents, and adults who struggle at school, home, or work.

Stimulants Outlook

The stimulants segment is further divided into amphetamine, methylphenidate, lisdexamfetamine, dexmethylphenidate. The amphetamine segment witnessed the largest revenue share in the attention deficit hyperactivity disorder market in 2021. Amphetamine or dextroamphetamine are potent central nervous system (CNS) stimulants. These drugs indirectly act as sympathomimetic amines and are also used for treating narcolepsy and hyperactivity other than ADHD. This class of drugs increases the focus on any activity, raises the ability to pay attention, and also assists in controlling impulsive behavioral symptoms.

Non- Stimulants Outlook

The non-stimulants segment is further classified into atomoxetine, guanfacine, clonidine, and others. The atomoxetine segment acquired the maximum revenue share in the attention deficit hyperactivity disorder market in 2021. Compared to other ADHD medications, atomoxetine operates differently. Atomoxetine is a selective noradrenaline reuptake inhibitor (SNRI), and hence it raises the levels of noradrenaline, which transports messages across brain cells, in the brain. By boosting this neurotransmitter, people with ADHD are able to improve focus and impulse control.

Demographics Outlook

On the basis of demographics, the attention deficit hyperactivity disorder market is fragmented into children (2 to 17 years of age) and adults. The children segment witnessed a substantial revenue share in the attention deficit hyperactivity disorder market in 2021. Children with ADHD find it challenging to control their impulsive behaviors, which can include anything from speech to movement to concentration. As a result, these kids are occasionally referred to as troublemakers or chastised for their laziness and lack of discipline.

Distribution Channel Outlook

Based on distribution channel, the attention deficit hyperactivity disorder market is segmented into retail pharmacy and hospital pharmacy. The retail pharmacy segment recorded the largest revenue share in the attention deficit hyperactivity disorder market in 2021. The majority of ADHD patients receive their care in outpatient settings, which has mainly given the segment its growth. Increased attention is also being paid to patient care initiatives to offer patients personal Electronic Health Records (EHRs) to keep track of their medical histories and receive primary care.

Regional Outlook

On the basis of region, the attention deficit hyperactivity disorder market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the maximum revenue share in the attention deficit hyperactivity disorder market in 2021. The widespread introduction and quick acceptance of various ADHD medications are the primary factors influencing the segment's growth. Growth is further anticipated by better patient affordability, favorable reimbursement policies, and rising public awareness of current treatment modalities.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, Pfizer, Inc. (Global Blood Therapeutics, Inc.), Johnson & Johnson (Johnson & Johnson Services, Inc.), Lupin Limited, Novartis AG, Takeda Pharmaceutical Company Limited, Mallinckrodt PLC, Purdue Pharma L.P., Aytu BioPharma, Inc. and Supernus Pharmaceuticals, Inc.

Strategies deployed in Attention Deficit Hyperactivity Disorder Market

Jan-2022: Eli Lilly and Company completed the acquisition of Prevail Therapeutics Inc., a gene therapy company. This acquisition forms a new manner for drug discovery and development at Lilly, broadening Lilly's research efforts through the creation of a gene therapy program that would be strengthened by Prevail's offerings of preclinical and clinical neuroscience assets.

Jul-2021: Eli Lilly and Company took over Protomer Technologies, a private biotech company. Under this acquisition, Protomer's glucose-sensing insulin program based on its proprietary molecular engineering of protein sensors (MEPS) platform is showing better results and Lilly would increase its diabetes portfolio with Lilly's innovative technology.

Jul-2021: Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., received FDA approval for a supplemental New Drug Application (sNDA) to modify the prescribing details for Adhansia XR® (methylphenidate hydrochloride) extended-release capsules CII. The sNDA approval was based on data from a Phase 3 Adult Laboratory Classroom (ALC), placebo-controlled, parallel-group, randomized, double-blind study analyzing the safety and accuracy of Adhansia XR in adult patients diagnosed with ADHD.

Apr-2021: Supernus Pharmaceuticals, Inc. received FDA approval for Qelbree, viloxazine extended-release capsules. The product treats attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age. Qelbree serves prescribing physicians and patients living with ADHD a therapy that is not a controlled substance with proven efficacy and a tolerable safety profile.

Mar-2019: Novartis received FDA approval for Mayzent, a medicine for the treatment of adults with relapsing forms of multiple sclerosis consisting of relapsing-remitting multiple sclerosis, clinically isolated syndrome, and secondary progressive multiple sclerosis (SPMS) with active disease. The Product hinders disability progression and preserving cognition.

Oct-2018: Neos Therapeutics, Inc., merged with Aytu BioPharma, Inc. got FDA approval for Cotempla XR-ODT, the first methylphenidate extended-release orally disintegrating tablet. The product treats attention-deficit/hyperactivity disorder (ADHD) in patients within the age group of 6 to 17 years old.

May-2018: Novartis received FDA approval for Aimovig, a prescription medicine used for the preventive treatment of migraine in adults. The product is a novel therapeutic approach as one of the FDA-approved treatments mainly developed to stop migraine by blocking the calcitonin gene-related peptide receptor (CGRP-R) that plays a major role in migraine.

Feb-2018: Neos Therapeutics, Inc., merged with Aytu BioPharma, Inc. announced the launch of Adzenys ERTM Extended-Release Oral Suspension, creating Neos' third ADHD product. Neos Therapeutics, Inc.'s increasing ADHD Product offerings show the strength of the company's technology platform and Neos Therapeutics capability to develop, manufacture, and commercialize products.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

  • Stimulants
    • Amphetamine
    • Methylphenidate
    • Lisdexamfetamine
    • Dexmethylphenidate
  • Non-stimulants
    • Atomoxetine
    • Guanfacine
    • Clonidine
    • Others

By Demographics

  • Adults
  • Children

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled:

  • Eli Lilly And Company
  • Pfizer, Inc. (Global Blood Therapeutics, Inc.)
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • Lupin Limited
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mallinckrodt PLC
  • Purdue Pharma L.P.
  • Aytu BioPharma, Inc.
  • Supernus Pharmaceuticals, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Attention Deficit Hyperactivity Disorder Market, by Drug Type
    • 1.4.2 Global Attention Deficit Hyperactivity Disorder Market, by Demographics
    • 1.4.3 Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel
    • 1.4.4 Global Attention Deficit Hyperactivity Disorder Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Attention Deficit Hyperactivity Disorder Market

Chapter 4. Global Attention Deficit Hyperactivity Disorder Market by Drug Type

  • 4.1 Global Stimulants Market by Region
  • 4.2 Global Attention Deficit Hyperactivity Disorder Market by Stimulants Type
    • 4.2.1 Global Amphetamine Market by Region
    • 4.2.2 Global Methylphenidate Market by Region
    • 4.2.3 Global Lisdexamfetamine Market by Region
    • 4.2.4 Global Dexmethylphenidate Market by Region
  • 4.3 Global Non-stimulants Market by Region
  • 4.4 Global Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
    • 4.4.1 Global Atomoxetine Market by Region
    • 4.4.2 Global Guanfacine Market by Region
    • 4.4.3 Global Clonidine Market by Region
    • 4.4.4 Global Others Market by Region

Chapter 5. Global Attention Deficit Hyperactivity Disorder Market by Demographics

  • 5.1 Global Adults Market by Region
  • 5.2 Global Children Market by Region

Chapter 6. Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel

  • 6.1 Global Retail Pharmacy Market by Region
  • 6.2 Global Hospital Pharmacy Market by Region

Chapter 7. Global Attention Deficit Hyperactivity Disorder Market by Region

  • 7.1 North America Attention Deficit Hyperactivity Disorder Market
    • 7.1.1 North America Attention Deficit Hyperactivity Disorder Market by Drug Type
      • 7.1.1.1 North America Stimulants Market by Country
      • 7.1.1.2 North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type
        • 7.1.1.2.1 North America Amphetamine Market by Country
        • 7.1.1.2.2 North America Methylphenidate Market by Country
        • 7.1.1.2.3 North America Lisdexamfetamine Market by Country
        • 7.1.1.2.4 North America Dexmethylphenidate Market by Country
      • 7.1.1.3 North America Non-stimulants Market by Country
      • 7.1.1.4 North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.1.1.4.1 North America Atomoxetine Market by Country
        • 7.1.1.4.2 North America Guanfacine Market by Country
        • 7.1.1.4.3 North America Clonidine Market by Country
        • 7.1.1.4.4 North America Others Market by Country
    • 7.1.2 North America Attention Deficit Hyperactivity Disorder Market by Demographics
      • 7.1.2.1 North America Adults Market by Country
      • 7.1.2.2 North America Children Market by Country
    • 7.1.3 North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.1.3.1 North America Retail Pharmacy Market by Country
      • 7.1.3.2 North America Hospital Pharmacy Market by Country
    • 7.1.4 North America Attention Deficit Hyperactivity Disorder Market by Country
      • 7.1.4.1 US Attention Deficit Hyperactivity Disorder Market
        • 7.1.4.1.1 US Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.1.4.1.1.1 US Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.1.4.1.1.2 US Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.1.4.1.2 US Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.1.4.1.3 US Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.1.4.2 Canada Attention Deficit Hyperactivity Disorder Market
        • 7.1.4.2.1 Canada Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.1.4.2.1.1 Canada Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.1.4.2.1.2 Canada Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.1.4.2.2 Canada Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.1.4.2.3 Canada Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.1.4.3 Mexico Attention Deficit Hyperactivity Disorder Market
        • 7.1.4.3.1 Mexico Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.1.4.3.1.1 Mexico Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.1.4.3.1.2 Mexico Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.1.4.3.2 Mexico Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.1.4.3.3 Mexico Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.1.4.4 Rest of North America Attention Deficit Hyperactivity Disorder Market
        • 7.1.4.4.1 Rest of North America Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.1.4.4.1.1 Rest of North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.1.4.4.1.2 Rest of North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.1.4.4.2 Rest of North America Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.1.4.4.3 Rest of North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel
  • 7.2 Europe Attention Deficit Hyperactivity Disorder Market
    • 7.2.1 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type
      • 7.2.1.1 Europe Stimulants Market by Country
      • 7.2.1.2 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type
        • 7.2.1.2.1 Europe Amphetamine Market by Country
        • 7.2.1.2.2 Europe Methylphenidate Market by Country
        • 7.2.1.2.3 Europe Lisdexamfetamine Market by Country
        • 7.2.1.2.4 Europe Dexmethylphenidate Market by Country
      • 7.2.1.3 Europe Non-stimulants Market by Country
      • 7.2.1.4 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.1.4.1 Europe Atomoxetine Market by Country
        • 7.2.1.4.2 Europe Guanfacine Market by Country
        • 7.2.1.4.3 Europe Clonidine Market by Country
        • 7.2.1.4.4 Europe Others Market by Country
    • 7.2.2 Europe Attention Deficit Hyperactivity Disorder Market by Demographics
      • 7.2.2.1 Europe Adults Market by Country
      • 7.2.2.2 Europe Children Market by Country
    • 7.2.3 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.3.1 Europe Retail Pharmacy Market by Country
      • 7.2.3.2 Europe Hospital Pharmacy Market by Country
    • 7.2.4 Europe Attention Deficit Hyperactivity Disorder Market by Country
      • 7.2.4.1 Germany Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.1.1 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.1.1.1 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.1.1.2 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.1.2 Germany Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.1.3 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.4.2 UK Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.2.1 UK Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.2.1.1 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.2.1.2 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.2.2 UK Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.2.3 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.4.3 France Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.3.1 France Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.3.1.1 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.3.1.2 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.3.2 France Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.3.3 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.4.4 Russia Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.4.1 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.4.1.1 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.4.1.2 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.4.2 Russia Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.4.3 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.4.5 Spain Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.5.1 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.5.1.1 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.5.1.2 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.5.2 Spain Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.5.3 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.4.6 Italy Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.6.1 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.6.1.1 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.6.1.2 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.6.2 Italy Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.6.3 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.2.4.7 Rest of Europe Attention Deficit Hyperactivity Disorder Market
        • 7.2.4.7.1 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.2.4.7.1.1 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.2.4.7.1.2 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.2.4.7.2 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.2.4.7.3 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel
  • 7.3 Asia Pacific Attention Deficit Hyperactivity Disorder Market
    • 7.3.1 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type
      • 7.3.1.1 Asia Pacific Stimulants Market by Country
      • 7.3.1.2 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type
        • 7.3.1.2.1 Asia Pacific Amphetamine Market by Country
        • 7.3.1.2.2 Asia Pacific Methylphenidate Market by Country
        • 7.3.1.2.3 Asia Pacific Lisdexamfetamine Market by Country
        • 7.3.1.2.4 Asia Pacific Dexmethylphenidate Market by Country
      • 7.3.1.3 Asia Pacific Non-stimulants Market by Country
      • 7.3.1.4 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.1.4.1 Asia Pacific Atomoxetine Market by Country
        • 7.3.1.4.2 Asia Pacific Guanfacine Market by Country
        • 7.3.1.4.3 Asia Pacific Clonidine Market by Country
        • 7.3.1.4.4 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics
      • 7.3.2.1 Asia Pacific Adults Market by Country
      • 7.3.2.2 Asia Pacific Children Market by Country
    • 7.3.3 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.3.1 Asia Pacific Retail Pharmacy Market by Country
      • 7.3.3.2 Asia Pacific Hospital Pharmacy Market by Country
    • 7.3.4 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country
      • 7.3.4.1 China Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.1.1 China Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.1.1.1 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.1.1.2 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.1.2 China Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.1.3 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.4.2 Japan Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.2.1 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.2.1.1 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.2.1.2 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.2.2 Japan Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.2.3 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.4.3 India Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.3.1 India Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.3.1.1 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.3.1.2 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.3.2 India Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.3.3 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.4.4 South Korea Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.4.1 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.4.1.1 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.4.1.2 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.4.2 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.4.3 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.4.5 Singapore Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.5.1 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.5.1.1 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.5.1.2 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.5.2 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.5.3 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.4.6 Malaysia Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.6.1 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.6.1.1 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.6.1.2 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.6.2 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.6.3 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.3.4.7 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market
        • 7.3.4.7.1 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.3.4.7.1.1 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.3.4.7.1.2 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.3.4.7.2 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.3.4.7.3 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel
  • 7.4 LAMEA Attention Deficit Hyperactivity Disorder Market
    • 7.4.1 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type
      • 7.4.1.1 LAMEA Stimulants Market by Country
      • 7.4.1.2 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type
        • 7.4.1.2.1 LAMEA Amphetamine Market by Country
        • 7.4.1.2.2 LAMEA Methylphenidate Market by Country
        • 7.4.1.2.3 LAMEA Lisdexamfetamine Market by Country
        • 7.4.1.2.4 LAMEA Dexmethylphenidate Market by Country
      • 7.4.1.3 LAMEA Non-stimulants Market by Country
      • 7.4.1.4 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.1.4.1 LAMEA Atomoxetine Market by Country
        • 7.4.1.4.2 LAMEA Guanfacine Market by Country
        • 7.4.1.4.3 LAMEA Clonidine Market by Country
        • 7.4.1.4.4 LAMEA Others Market by Country
    • 7.4.2 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics
      • 7.4.2.1 LAMEA Adults Market by Country
      • 7.4.2.2 LAMEA Children Market by Country
    • 7.4.3 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.3.1 LAMEA Retail Pharmacy Market by Country
      • 7.4.3.2 LAMEA Hospital Pharmacy Market by Country
    • 7.4.4 LAMEA Attention Deficit Hyperactivity Disorder Market by Country
      • 7.4.4.1 Brazil Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.1.1 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.1.1.1 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.1.1.2 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.1.2 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.1.3 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.4.2 Argentina Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.2.1 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.2.1.1 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.2.1.2 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.2.2 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.2.3 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.4.3 UAE Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.3.1 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.3.1.1 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.3.1.2 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.3.2 UAE Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.3.3 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.4.4 Saudi Arabia Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.4.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.4.1.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.4.1.2 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.4.2 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.4.3 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.4.5 South Africa Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.5.1 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.5.1.1 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.5.1.2 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.5.2 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.5.3 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.4.6 Nigeria Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.6.1 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.6.1.1 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.6.1.2 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.6.2 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.6.3 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel
      • 7.4.4.7 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market
        • 7.4.4.7.1 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type
          • 7.4.4.7.1.1 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type
          • 7.4.4.7.1.2 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
        • 7.4.4.7.2 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics
        • 7.4.4.7.3 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 Eli Lilly And Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Acquisition and Mergers:
  • 8.2 Pfizer, Inc. (Global Blood Therapeutics, Inc.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional & Segmental Analysis
    • 8.2.4 Research & Development Expense
  • 8.4 Lupin Limited
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
  • 8.5 Novartis AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Approvals and Trials:
  • 8.6 Takeda Pharmaceutical Company Limited
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Mallinckrodt PLC
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
  • 8.8 Purdue Pharma L.P.
    • 8.8.1 Company Overview
    • 8.8.2 Recent strategies and developments:
      • 8.8.2.1 Approvals and Trials:
  • 8.9 Aytu BioPharma, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Product Launches and Product Expansions:
      • 8.9.5.2 Approvals and Trials:
  • 8.10. Supernus Pharmaceuticals, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Research & Development Expenses
    • 8.10.4 Recent strategies and developments:
      • 8.10.4.1 Approvals and Trials:

LIST OF TABLES

  • TABLE 1 Global Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 2 Global Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 3 Global Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 4 Global Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 5 Global Stimulants Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Stimulants Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 8 Global Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 9 Global Amphetamine Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Amphetamine Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Methylphenidate Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Methylphenidate Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Lisdexamfetamine Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Lisdexamfetamine Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Dexmethylphenidate Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Dexmethylphenidate Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Non-stimulants Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Non-stimulants Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 20 Global Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 21 Global Atomoxetine Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Atomoxetine Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Guanfacine Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Guanfacine Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Clonidine Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Clonidine Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 30 Global Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 31 Global Adults Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Adults Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Children Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Children Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 36 Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 37 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 38 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 39 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 40 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 41 Global Attention Deficit Hyperactivity Disorder Market by Region, 2018 - 2021, USD Million
  • TABLE 42 Global Attention Deficit Hyperactivity Disorder Market by Region, 2022 - 2028, USD Million
  • TABLE 43 North America Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 44 North America Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 45 North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 46 North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 47 North America Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 50 North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 51 North America Amphetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Amphetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Methylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Methylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Non-stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Non-stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 61 North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 62 North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 63 North America Atomoxetine Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Atomoxetine Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Guanfacine Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Guanfacine Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Clonidine Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Clonidine Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 72 North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 73 North America Adults Market by Country, 2018 - 2021, USD Million
  • TABLE 74 North America Adults Market by Country, 2022 - 2028, USD Million
  • TABLE 75 North America Children Market by Country, 2018 - 2021, USD Million
  • TABLE 76 North America Children Market by Country, 2022 - 2028, USD Million
  • TABLE 77 North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 78 North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 79 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 80 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 81 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 82 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 83 North America Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 84 North America Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 85 US Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 86 US Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 87 US Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 88 US Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 89 US Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 90 US Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 91 US Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 92 US Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 93 US Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 94 US Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 95 US Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 96 US Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 97 Canada Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 98 Canada Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 99 Canada Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 100 Canada Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 101 Canada Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 102 Canada Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 103 Canada Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 104 Canada Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 105 Canada Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 106 Canada Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 107 Canada Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 108 Canada Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 109 Mexico Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 110 Mexico Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 111 Mexico Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 112 Mexico Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 113 Mexico Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 114 Mexico Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 115 Mexico Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 116 Mexico Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 117 Mexico Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 118 Mexico Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 119 Mexico Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 120 Mexico Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 121 Rest of North America Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 122 Rest of North America Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 123 Rest of North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 124 Rest of North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 125 Rest of North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 126 Rest of North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 127 Rest of North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 128 Rest of North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 129 Rest of North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 130 Rest of North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 131 Rest of North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 132 Rest of North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 133 Europe Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 134 Europe Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 135 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 136 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 137 Europe Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Europe Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 139 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 140 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 141 Europe Amphetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 142 Europe Amphetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 143 Europe Methylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Europe Methylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Europe Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Europe Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 147 Europe Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Europe Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Europe Non-stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 150 Europe Non-stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 151 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 152 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 153 Europe Atomoxetine Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Europe Atomoxetine Market by Country, 2022 - 2028, USD Million
  • TABLE 155 Europe Guanfacine Market by Country, 2018 - 2021, USD Million
  • TABLE 156 Europe Guanfacine Market by Country, 2022 - 2028, USD Million
  • TABLE 157 Europe Clonidine Market by Country, 2018 - 2021, USD Million
  • TABLE 158 Europe Clonidine Market by Country, 2022 - 2028, USD Million
  • TABLE 159 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 160 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 161 Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 162 Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 163 Europe Adults Market by Country, 2018 - 2021, USD Million
  • TABLE 164 Europe Adults Market by Country, 2022 - 2028, USD Million
  • TABLE 165 Europe Children Market by Country, 2018 - 2021, USD Million
  • TABLE 166 Europe Children Market by Country, 2022 - 2028, USD Million
  • TABLE 167 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 170 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 171 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 172 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 173 Europe Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 174 Europe Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 175 Germany Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 176 Germany Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 177 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 178 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 179 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 180 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 181 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 182 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 183 Germany Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 184 Germany Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 185 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 186 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 187 UK Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 188 UK Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 189 UK Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 190 UK Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 191 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 192 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 193 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 194 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 195 UK Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 196 UK Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 197 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 198 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 199 France Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 200 France Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 201 France Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 202 France Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 203 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 204 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 205 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 206 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 207 France Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 208 France Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 209 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 210 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 211 Russia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 212 Russia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 213 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 214 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 215 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 216 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 217 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 218 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 219 Russia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 220 Russia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 221 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 222 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 223 Spain Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 224 Spain Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 225 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 226 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 227 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 228 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 229 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 230 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 231 Spain Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 232 Spain Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 233 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 234 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 235 Italy Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 236 Italy Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 237 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 238 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 239 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 240 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 241 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 242 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 243 Italy Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 244 Italy Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 245 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 246 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 247 Rest of Europe Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 248 Rest of Europe Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 249 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 250 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 251 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 252 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 253 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 254 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 255 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 256 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 257 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 258 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 259 Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 260 Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 261 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 262 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 263 Asia Pacific Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 264 Asia Pacific Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 265 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 266 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 267 Asia Pacific Amphetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 268 Asia Pacific Amphetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 269 Asia Pacific Methylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 270 Asia Pacific Methylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 271 Asia Pacific Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 272 Asia Pacific Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 273 Asia Pacific Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 274 Asia Pacific Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 275 Asia Pacific Non-stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 276 Asia Pacific Non-stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 277 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 278 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 279 Asia Pacific Atomoxetine Market by Country, 2018 - 2021, USD Million
  • TABLE 280 Asia Pacific Atomoxetine Market by Country, 2022 - 2028, USD Million
  • TABLE 281 Asia Pacific Guanfacine Market by Country, 2018 - 2021, USD Million
  • TABLE 282 Asia Pacific Guanfacine Market by Country, 2022 - 2028, USD Million
  • TABLE 283 Asia Pacific Clonidine Market by Country, 2018 - 2021, USD Million
  • TABLE 284 Asia Pacific Clonidine Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 286 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 287 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 288 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 289 Asia Pacific Adults Market by Country, 2018 - 2021, USD Million
  • TABLE 290 Asia Pacific Adults Market by Country, 2022 - 2028, USD Million
  • TABLE 291 Asia Pacific Children Market by Country, 2018 - 2021, USD Million
  • TABLE 292 Asia Pacific Children Market by Country, 2022 - 2028, USD Million
  • TABLE 293 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 294 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 295 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 296 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 297 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 298 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 299 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 300 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 301 China Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 302 China Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 303 China Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 304 China Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 305 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 306 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 307 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 308 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 309 China Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 310 China Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 311 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 312 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 313 Japan Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 314 Japan Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 315 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 316 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 317 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 318 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 319 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 320 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 321 Japan Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 322 Japan Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 323 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 324 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 325 India Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 326 India Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 327 India Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 328 India Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 329 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 330 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 331 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 332 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 333 India Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 334 India Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 335 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 336 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 337 South Korea Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 338 South Korea Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 339 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 340 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 341 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 342 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 343 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 344 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 345 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 346 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 347 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 348 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 349 Singapore Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 350 Singapore Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 351 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 352 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 353 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 354 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 355 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 356 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 357 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 358 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 359 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 360 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 361 Malaysia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 362 Malaysia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 363 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 364 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 365 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 366 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 367 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 368 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 369 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 370 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 371 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 372 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 373 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 374 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 375 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 376 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 377 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 378 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 379 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 380 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 381 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 382 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 383 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 384 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 385 LAMEA Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 386 LAMEA Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 387 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 388 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 389 LAMEA Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 390 LAMEA Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 391 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 392 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 393 LAMEA Amphetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 394 LAMEA Amphetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 395 LAMEA Methylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 396 LAMEA Methylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 397 LAMEA Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
  • TABLE 398 LAMEA Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
  • TABLE 399 LAMEA Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
  • TABLE 400 LAMEA Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
  • TABLE 401 LAMEA Non-stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 402 LAMEA Non-stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 403 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 404 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 405 LAMEA Atomoxetine Market by Country, 2018 - 2021, USD Million
  • TABLE 406 LAMEA Atomoxetine Market by Country, 2022 - 2028, USD Million
  • TABLE 407 LAMEA Guanfacine Market by Country, 2018 - 2021, USD Million
  • TABLE 408 LAMEA Guanfacine Market by Country, 2022 - 2028, USD Million
  • TABLE 409 LAMEA Clonidine Market by Country, 2018 - 2021, USD Million
  • TABLE 410 LAMEA Clonidine Market by Country, 2022 - 2028, USD Million
  • TABLE 411 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 412 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 413 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 414 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 415 LAMEA Adults Market by Country, 2018 - 2021, USD Million
  • TABLE 416 LAMEA Adults Market by Country, 2022 - 2028, USD Million
  • TABLE 417 LAMEA Children Market by Country, 2018 - 2021, USD Million
  • TABLE 418 LAMEA Children Market by Country, 2022 - 2028, USD Million
  • TABLE 419 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 420 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 421 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 422 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 423 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 424 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 425 LAMEA Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
  • TABLE 426 LAMEA Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
  • TABLE 427 Brazil Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 428 Brazil Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 429 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 430 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 431 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 432 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 433 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 434 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 435 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 436 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 437 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 438 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 439 Argentina Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 440 Argentina Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 441 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 442 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 443 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 444 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 445 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 446 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 447 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 448 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 449 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 450 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 451 UAE Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 452 UAE Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 453 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 454 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 455 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 456 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 457 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 458 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 459 UAE Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 460 UAE Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 461 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 462 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 463 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 464 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 465 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 466 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 467 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 468 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 469 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 470 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 471 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 472 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 473 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 474 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 475 South Africa Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 476 South Africa Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 477 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 478 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 479 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 480 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 481 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 482 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 483 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 484 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 485 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 486 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 487 Nigeria Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 488 Nigeria Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 489 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 490 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 491 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 492 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 493 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 494 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 495 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 496 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 497 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 498 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 499 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
  • TABLE 500 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
  • TABLE 501 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
  • TABLE 502 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
  • TABLE 503 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
  • TABLE 504 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
  • TABLE 505 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
  • TABLE 506 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
  • TABLE 507 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
  • TABLE 508 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
  • TABLE 509 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 510 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 511 Key Information - Eli Lilly And Company
  • TABLE 512 Key Information - Pfizer, Inc.
  • TABLE 513 Key Information - Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • TABLE 514 Key Information - Lupin Limited
  • TABLE 515 Key Information - Novartis AG
  • TABLE 516 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 517 Key information - Mallinckrodt PLC
  • TABLE 518 Key Information - Purdue Pharma L.P.
  • TABLE 519 Key Information - AYTU BIOPHARMA, INC.
  • TABLE 520 Key Information - Supernus Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIG 1 Methodology for the research
  • FIG 2 Global Attention Deficit Hyperactivity Disorder Market Share by Drug Type, 2021
  • FIG 3 Global Attention Deficit Hyperactivity Disorder Market Share by Drug Type, 2028
  • FIG 4 Global Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2028, USD Million
  • FIG 5 Global Attention Deficit Hyperactivity Disorder Market Share by Demographics, 2021
  • FIG 6 Global Attention Deficit Hyperactivity Disorder Market Share by Demographics, 2028
  • FIG 7 Global Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2028, USD Million
  • FIG 8 Global Attention Deficit Hyperactivity Disorder Market Share by Distribution Channel, 2021
  • FIG 9 Global Attention Deficit Hyperactivity Disorder Market Share by Distribution Channel, 2028
  • FIG 10 Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 11 Global Attention Deficit Hyperactivity Disorder Market Share by Region, 2021
  • FIG 12 Global Attention Deficit Hyperactivity Disorder Market Share by Region, 2028
  • FIG 13 Global Attention Deficit Hyperactivity Disorder Market by Region, 2018 - 2028, USD Millione